Published : Nov-2019
No. of Pages : 68
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Organ Function Assays Overview 6
3 Products under Development 7
3.1 Organ Function Assays - Pipeline Products by Stage of Development 7
3.2 Organ Function Assays - Pipeline Products by Territory 8
3.3 Organ Function Assays - Pipeline Products by Regulatory Path 9
3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date 10
3.5 Organ Function Assays - Ongoing Clinical Trials 11
4 Organ Function Assays - Pipeline Products under Development by Companies 12
4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development 12
4.2 Organ Function Assays - Pipeline Products by Stage of Development 13
5 Organ Function Assays Companies and Product Overview 14
5.1 Boditech Med Inc Company Overview 14
5.1.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 China Medical Technologies Inc (Inactive) Company Overview 15
5.2.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Cornell University Company Overview 18
5.3.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Daxor Corp Company Overview 19
5.4.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 DSX Therapeutics LLC Company Overview 20
5.5.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 French National Institute of Health and Medical Research Company Overview 21
5.6.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 HepQuant Llc Company Overview 22
5.7.1 HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Humedics GmbH Company Overview 28
5.8.1 Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Merck Millipore Corp Company Overview 29
5.9.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Myriad Genetics Inc Company Overview 30
5.10.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Proteome Sciences Plc Company Overview 31
5.11.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Radboud University Medical Centre Company Overview 32
5.12.1 Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Schnellgen, Inc Company Overview 33
5.13.1 Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
6 Organ Function Assays- Recent Developments 34
6.1 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters 34
6.2 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members 34
6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 35
6.4 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors 36
6.5 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results 36
6.6 Aug 01, 2019: CareDx reports second quarter 2019 results 38
6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 39
6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 41
6.9 Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board 41
6.10 May 08, 2019: CareDx reports first quarter 2019 results 42
6.11 May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results 43
6.12 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 44
6.13 Apr 04, 2019: HepQuant's Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117 45
6.14 Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results 46
6.15 Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018 48
6.16 Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager 48
6.17 Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test 49
6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 49
6.19 Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results 50
6.20 Jan 23, 2019: Proteome Sciences: Year-end trading update 51
6.21 Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results 52
6.22 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away 54
6.23 Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA 55
6.24 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 55
6.25 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 56
6.26 Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer 57
6.27 Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer 57
6.28 Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit 58
6.29 Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members 58
6.30 Nov 08, 2018: CareDx reports third quarter results 61
6.31 Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 62
6.32 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 63
7 Appendix 65
7.1 Methodology 65
7.2 About GlobalData 68
7.3 Contact Us 68
7.4 Disclaimer 68
List of Tables
Table 1: Organ Function Assays - Pipeline Products by Stage of Development 7
Table 2: Organ Function Assays - Pipeline Products by Territory 8
Table 3: Organ Function Assays - Pipeline Products by Regulatory Path 9
Table 4: Organ Function Assays - Pipeline Products by Estimated Approval Date 10
Table 5: Organ Function Assays - Ongoing Clinical Trials 11
Table 6: Organ Function Assays Companies - Pipeline Products by Stage of Development 12
Table 7: Organ Function Assays - Pipeline Products by Stage of Development 13
Table 8: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
Table 18: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 44: Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 53: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 56: Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview 32
Table 59: Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 62: Glossary 67
List of Figures
Figure 1: Organ Function Assays - Pipeline Products by Stage of Development 7
Figure 2: Organ Function Assays - Pipeline Products by Territory 8
Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path 9
Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date 10
Figure 5: Organ Function Assays - Ongoing Clinical Trials 11
